{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:30:13Z","timestamp":1786962613213,"version":"build-2736575974"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"31","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100016319","name":"China National Biotec Group Company","doi-asserted-by":"publisher","award":["CNBG-FNJ-003"],"award-info":[{"award-number":["CNBG-FNJ-003"]}],"id":[{"id":"10.13039\/501100016319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016319","name":"China National Biotec Group Company","doi-asserted-by":"publisher","award":["ZSVG-02-MRD-03"],"award-info":[{"award-number":["ZSVG-02-MRD-03"]}],"id":[{"id":"10.13039\/501100016319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016319","name":"China National Biotec Group Company","doi-asserted-by":"publisher","award":["ZSVG-COM-2201"],"award-info":[{"award-number":["ZSVG-COM-2201"]}],"id":[{"id":"10.13039\/501100016319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>LNP-mediated mRNA delivery encounters challenges with insufficient efficacy, poor safety, and unstable performance. Moreover, the distinct requirements of in vitro and in vivo applications call for specific LNP strategies. To address this, we developed two complementary LNP strategies tailored to different application scenarios: one optimized for in vitro transfection efficiency and the other enhanced for in vivo delivery performance. For the in vitro-oriented strategy, \u03b2-sitosterol was used to replace cholesterol in LNPs. The resulting \u03b2-sitosterol-based LNPs displayed distinct internal fingerprint structures visualized by Cryo-TEM and markedly enhanced in vitro protein expression by two orders of magnitude, making it a high-efficiency tool for in vitro mRNA delivery. However, this modification did not enhance in vivo transfection efficiency and led to a significant reduction in LNP stability, confirming its suitability for in vitro use only. For the in vivo-oriented strategy, eight vitamin-conjugated ionizable lipids were synthesized. Six of these lipids were selected for animal screening, and two exhibited higher in vivo protein expression levels compared with the commercial LNP control. Accelerated stability studies demonstrated that LNPs containing these vitamin-conjugated ionizable lipids had good stability. Furthermore, the optimized in vivo-oriented LNP was used to encapsulate varicella-zoster virus (VZV) mRNA and respiratory syncytial virus (RSV) mRNA, and animal immunization experiments showed that it induced superior immunogenicity at a lower dose than the commercial delivery system. In vivo safety studies further confirmed that the in vivo-oriented LNPs had a better safety profile than commercial LNPs, with no obvious cytotoxicity or adverse reactions. Herein, we developed two complementary LNP strategies based on cholesterol analogs and vitamin-conjugated ionizable lipids, which address the limitations of traditional LNP systems, providing targeted solutions for both in vitro and in vivo translational applications.<\/jats:p>","DOI":"10.1021\/acsami.6c11233","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:19:06Z","timestamp":1785849546000},"page":"42417-42427","source":"Crossref","is-referenced-by-count":0,"title":["Cholesterol Analogs and Vitamin-Conjugated Ionizable Lipids Enhance Lipid Nanoparticle Delivery for In Vitro and In Vivo Applications"],"prefix":"10.1021","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9547-0659","authenticated-orcid":true,"given":"Chenglong","family":"Wang","sequence":"first","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Gao","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuo","family":"Zhou","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Wu","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Liang","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Pan","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jia","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]},{"name":"Shanghai-Virogin Biotech Co., Ltd. , ,","place":["Shanghai, China, 201800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4189-4469","authenticated-orcid":true,"given":"Tengjie","family":"Wu","sequence":"additional","affiliation":[{"name":"CNBG-Virogin Biotech (Shanghai) Co., Ltd. , ,","place":["Shanghai, China, 201800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhang","sequence":"additional","affiliation":[{"name":"China National Biotech Group (CNBG) Co., Ltd. , , ,","place":["Beijing, China, 100024"]},{"name":"Sinopharm Group China National Biotech Group (CNBG) Co., Ltd. , ,","place":["Beijing, China, 100124"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026081706072197800_cit1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60040-9","article-title":"Freezing induced incorporation of betaine in lipid nanoparticles enhances mRNA delivery","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"2026081706072197800_cit2","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/s41551-025-01422-8","article-title":"Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity","volume":"9","author":"Gong","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"2026081706072197800_cit3","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1038\/s41467-025-61688-z","article-title":"Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"2026081706072197800_cit4","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41563-025-02240-8","article-title":"Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity","volume":"24","author":"Luozhong","year":"2025","journal-title":"Nat. Mater."},{"key":"2026081706072197800_cit5","doi-asserted-by":"publisher","first-page":"31530","DOI":"10.1021\/jacs.5c05367","article-title":"Breaking Endosomal Barriers: Thiol-Mediated Uptake Lipid Nanoparticles for Efficient mRNA Vaccine Delivery","volume":"147","author":"Lian","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026081706072197800_cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123541","article-title":"Biodegradable polymers with tertiary amines enhance mRNA delivery of lipid nanoparticles via improved endosomal escape","volume":"324","author":"Zhao","year":"2026","journal-title":"Biomaterials"},{"key":"2026081706072197800_cit7","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202507657","article-title":"Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas","volume":"37","author":"Isaac","year":"2025","journal-title":"Adv. Mater."},{"key":"2026081706072197800_cit8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"2026081706072197800_cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2026081706072197800_cit10","doi-asserted-by":"publisher","DOI":"10.1002\/bmm2.12116","article-title":"Principles of lipid nanoparticle design for mRNA delivery","volume":"3","author":"Zhang","year":"2025","journal-title":"BMEMat"},{"key":"2026081706072197800_cit11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J. Control. Release"},{"key":"2026081706072197800_cit12","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"2026081706072197800_cit13","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12237","article-title":"Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes","volume":"24","author":"Hattori","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"2026081706072197800_cit14","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1039\/d4bm01070a","article-title":"Formulation of lipid nanoparticles containing ginsenoside Rg2 and protopanaxadiol for highly efficient delivery of mRNA","volume":"12","author":"Park","year":"2024","journal-title":"Biomater. Sci."},{"key":"2026081706072197800_cit15","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1021\/acs.nanolett.0c01386","article-title":"Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery","volume":"20","author":"Eygeris","year":"2020","journal-title":"Nano Lett."},{"key":"2026081706072197800_cit16","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1039\/d0bm01947j","article-title":"Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery","volume":"9","author":"Herrera","year":"2021","journal-title":"Biomater. Sci."},{"key":"2026081706072197800_cit17","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303261","article-title":"Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"2026081706072197800_cit18","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"key":"2026081706072197800_cit19","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1894","article-title":"The clinical progress and challenges of mRNA vaccines","volume":"15","author":"Yu","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"2026081706072197800_cit20","doi-asserted-by":"publisher","first-page":"37763","DOI":"10.1021\/acsami.5c08444","article-title":"Lipid Nanoparticles Consisting of Sterol-Conjugated Ionizable Lipids Enable Prolonged and Safe mRNA Delivery","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026081706072197800_cit21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2024.11.073","article-title":"Corosolic acid derivative-based lipid nanoparticles for efficient RNA delivery","volume":"378","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"2026081706072197800_cit22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"2026081706072197800_cit23","doi-asserted-by":"publisher","first-page":"20672","DOI":"10.1021\/acsnano.5c01378","article-title":"Iterative Screening of Vitamin E-Based Functional Lipid Nanoparticles for mRNA Delivery","volume":"19","author":"Cui","year":"2025","journal-title":"ACS Nano"},{"key":"2026081706072197800_cit24","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1021\/acsami.4c14203","article-title":"Ionizable Cholesterol Analogs as the Fifth Component of Lipid Nanoparticles for Selective Targeting Delivery of mRNA","volume":"17","author":"Liu","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026081706072197800_cit25","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202503034","article-title":"Endogenous Corticosteroid Derived Lipid Nanoparticles (Cortico LNPs) Enable Selective mRNA Delivery to the Spleen","volume":"21","author":"Isaac","year":"2025","journal-title":"Small"},{"key":"2026081706072197800_cit26","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1038\/s41467-025-61114-4","article-title":"Budesonide-incorporated inhalable lipid nanoparticles for antiTSLP nanobody mRNA delivery to treat steroid-resistant asthma","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"2026081706072197800_cit27","doi-asserted-by":"publisher","first-page":"27977","DOI":"10.1021\/acsnano.5c10648","article-title":"Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization","volume":"19","author":"Kawaguchi","year":"2025","journal-title":"ACS Nano"},{"key":"2026081706072197800_cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.123015","article-title":"Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations","volume":"1186","author":"Jia","year":"2021","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"2026081706072197800_cit29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jconrel.2020.01.049","article-title":"Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation","volume":"320","author":"Parot","year":"2020","journal-title":"J. Control. Release"},{"key":"2026081706072197800_cit30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030327","article-title":"An mRNA Vaccine for Herpes Zoster and Its Efficacy Evaluation in Na\u00efve\/Primed Murine Models","volume":"13","author":"Jiang","year":"2025","journal-title":"Vaccines"},{"key":"2026081706072197800_cit31","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s00216-018-0943-8","article-title":"A guide to large-scale RNA sample preparation","volume":"410","author":"Baronti","year":"2018","journal-title":"Anal. Bioanal. Chem."}],"container-title":["ACS Applied Materials &amp; Interfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsami.6c11233","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/31\/42417\/66333650\/am-2026-11233b.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/31\/42417\/66333650\/am-2026-11233b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:17:32Z","timestamp":1786961852000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aamick\/article\/18\/31\/42417\/5236948\/Cholesterol-Analogs-and-Vitamin-Conjugated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":31,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2026,7,29]]},"published-print":{"date-parts":[[2026,8,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acsami.6c11233","relation":{},"ISSN":["1944-8244","1944-8252"],"issn-type":[{"value":"1944-8244","type":"print"},{"value":"1944-8252","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}